Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eileen Francis

Reporter – US

Eileen Francis is a reporter for “The Tan Sheet,” where she follows news on OTC drug and nutritional product manufacturing, regulation, legislation, finance and research. She previously served as a reporter and editor of “The Rose Sheet,” IBI’s source for in-depth coverage of the cosmetics industry. Early in her career, Eileen worked in public relations and as a writer for a lobbying firm. Outside of IBI, her freelance work includes articles on business, art and travel.
Advertisement
Set Alert for Articles By Eileen Francis

Latest From Eileen Francis

Ranitidine Distribution Stops In Canada As Regulators Assess Contamination Threat

Health Canada asks ranitidine H2 blocker firms to halt sales until it gathers more information on NDMA contamination, which may form due to the drug’s instability. At least one marketer, Sandoz, also is recalling its ranitidine products in both Canada and US.

Europe Canada

Contamination In Common OTC Antacid Adds To FDA's API Impurity Concerns

FDA assessing contamination of Rx and OTC H2 blocker ranitidine to determine steps it should take. The contaminant, NDMA, is dangerous when consumed in large quantities, but has been found in H2 blockers at levels that don't pose a risk, FDA says.
United States Health

Online Pharmacy Stirs Ranitidine Controversy With Petition To Halt Sales

After its tests showed ranitidine forms a nitrosamine impurity that is a probable carcinogen, Valisure asks FDA to suspend sales of antacid products containing the API. In citizen petition firm, online pharmacy also advises FDA to publish regulations requiring independent chemical testing, verification of drugs.

United States Health

CBD Supplement Label, Claim Violations Form Perfect Storm For Class Actions

"Technical" label violations, "full-spectrum" claims could spur class actions in CBD supplement space, says attorney Justin Prochnow. At Natural Products Expo East, he says numerous entrants have no experience and labels are likely targets as no standards are recognized for product and ingredient descriptions.

Dietary Supplements Regulation

Perrigo Prioritizes Innovating First After Following OTC Brands To Market

Perrigo’s "national brand better" approach includes adding "better" value to generic equivalents that branded aren't offering, says President and CEO Murray Kessler. Prevacid 24 HR acquisition puts Perrigo at top of 15-mg lansoprazole PPI brand sales as well as in the generics market.

OTC Drugs Commercial

J&J Launches Neutrogena Bright Boost, Children's Tylenol Dissolve Packs

Neutrogena Bright Boost line launches with technology borrowed from J&J's recently acquired NeoStrata high-end skin care line, worldwide consumer health chief Thibaut Mongon says. J&J also launches Children’s Tylenol Dissolve Packs.

Cosmetics OTC Devices
See All
Advertisement
UsernamePublicRestriction

Register